71 - 80 out of 276Page size: 10
  1. 2021

  2. The effect of spike mutations on SARS-CoV-2 neutralization

    Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J. L., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C. F., Sanders, R. W., Gupta, R. K., Cherepanov, P., Stauss, H. J., Nastouli, E., Doores, K. J., van Gils, M. J., & 1 othersMcCoy, L. E., 23 Mar 2021, In: Cell reports. 34, 12, 108890.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Virus vaccines: proteins prefer prolines

    Sanders, R. W. & Moore, J. P., 10 Mar 2021, In: Cell host & microbe. 29, 3, p. 327-333 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S. G., Allen, J. D., Watanabe, Y., Giezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I., & 27 othersBurger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaître, J., Chapon, C., Fang, R. H. T., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B. L., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., le Grand, R. & Sanders, R. W., 4 Mar 2021, In: Cell. 184, 5, p. 1188-1200.e19 36 p., 365726.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

    Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H-J., Linty, F., Visser, R., Brinkhaus, M., Šuštić, T., de Taeye, S. W., Bentlage, A. E. H., Toivonen, S., Koeleman, C. A. M., Sainio, S., Kootstra, N. A., Brouwer, P. J. M., Geyer, C. E., Derksen, N. I. L., & 31 othersWolbink, G., de Winther, M., Sanders, R. W., van Gils, M. J., de Bruin, S., Vlaar, A. P. J., Rispens, T., den Dunnen, J., Amsterdam UMC COVID-19 Biobank, Zaaijer, H. L., Wuhrer, M., van der Schoot, C. E., Vidarsson, G., Study group members AMC, Wiersinga, W. J., de Bree, G. J., Geerlings, S. E., Goorhuis, B., Grobusch, M. P., Harris, V. C., Hermans, S. M., Hovius, J. W. R., Nellen, J., van der Poll, T., Prins, J. M., Stijnis, C. S., van der Valk, M., van Vugt, M., Hollmann, M. W., Preckel, P. D. . B. & Veelo, D. P., 26 Feb 2021, In: Science. 371, 6532, abc8378.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Antibody responses to SARS-CoV-2 mrna vaccines are detectable in Saliva

    Ketas, T. J., Chaturbhuj, D., Cruz Portillo, V. M., Francomano, E., Golden, E., Chandrasekhar, S., Debnath, G., Díaz-Tapia, R., Yasmeen, A., Kramer, K. D., Munawar, T., Leconet, W., Zhao, Z., Brouwer, P. J. M., Cushing, M. M., Sanders, R. W., Cupo, A., Klasse, P. J., Formenti, S. C. & Moore, J. P., 2021, In: Pathogens and Immunity. 6, 1, p. 116-134 19 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2020

  8. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

    Liu, H., Wu, N. C., Yuan, M., Bangaru, S., Torres, J. L., Caniels, T. G., van Schooten, J., Zhu, X., Lee, C-C. D., Brouwer, P. J. M., van Gils, M. J., Sanders, R. W., Ward, A. B. & Wilson, I. A., 15 Dec 2020, In: Immunity. 53, 6, p. 1272-1280.e5

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers

    Schorcht, A., van den Kerkhof, T. L. G. M., Cottrell, C. A., Allen, J. D., Torres, J. L., Behrens, A-J., Schermer, E. E., Burger, J. A., de Taeye, S. W., Torrents de la Peña, A., Bontjer, I., Gumbs, S., Ozorowski, G., LaBranche, C. C., de Val, N., Yasmeen, A., Klasse, P. J., Montefiori, D. C., Moore, J. P., Schuitemaker, H., & 4 othersCrispin, M., van Gils, M. J., Ward, A. B. & Sanders, R. W., Dec 2020, In: Journal of virology. 94, 24, e01214-20.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

    Wu, N. C., Yuan, M., Liu, H., Lee, C-C. D., Zhu, X., Bangaru, S., Torres, J. L., Caniels, T. G., Brouwer, P. J. M., van Gils, M. J., Sanders, R. W., Ward, A. B. & Wilson, I. A., 20 Oct 2020, In: Cell reports. 33, 3, 108274.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

    Pickering, S., Betancor, G., Galão, R. P., Merrick, B., Signell, A. W., Wilson, H. D., Kia Ik, M. T., Seow, J., Graham, C., Acors, S., Kouphou, N., Steel, K. J. A., Hemmings, O., Patel, A., Nebbia, G., Douthwaite, S., O'Connell, L., Luptak, J., McCoy, L. E., Brouwer, P., & 11 othersvan Gils, M. J., Sanders, R. W., Martinez Nunez, R., Bisnauthsing, K., O'Hara, G., MacMahon, E., Batra, R., Malim, M. H., Neil, S. J. D., Doores, K. J. & Edgeworth, J. D., 1 Sept 2020, In: PLoS pathogens. 16, 9, p. e1008817

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Een hiv-vaccin: Hoe ver zijn we?

    Reiss, E. I. M. M., van Gils, M. J., Sanders, R. W. & de Bree, G. J., 1 Sept 2020, In: Nederlands tijdschrift voor geneeskunde. 164, 37, D5167.

    Research output: Contribution to journal › Article › Professional

Previous 1...4 5 6 7 8 9 10 11 ...28 Next

ID: 82305